Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network

Rhea-AI Summary

Tharimmune (NASDAQ: THAR) commented on the DTCC and Digital Asset partnership to tokenize U.S. Treasury securities on the Canton Network announced December 18, 2025. The company highlighted that DTCC custody covers ~$30 trillion in U.S. Treasuries and noted Canton Network's $9 trillion monthly transaction volume and >700,000 daily transactions as validation of institutional blockchain adoption.

Tharimmune said it established a digital asset treasury strategy in November 2025 with a $545 million private placement, has acquired Canton Coin, and is pursuing roles as a Super Validator and application investor to support Canton Network expansion.

Positive

• $545 million private placement launched in November 2025
• $9 trillion monthly transaction volume on Canton Network
• DTCC custody represents ~$30 trillion in U.S. Treasury assets
• Pursuing Super Validator and application investor roles on Canton Network

Negative

• None.

Key Figures

U.S. Treasuries at DTCC $30 trillion U.S. Treasury assets custodied with DTCC mentioned in article

Monthly transaction volume $9 trillion Canton Network monthly transaction volume

Daily transactions 700,000 Canton Network daily transactions referenced by CEO

Private placement size $545 million November 2025 private placement to establish Canton Coin treasury strategy

Market Reality Check

$2.36 Last Close

Volume Volume 716,403 is well above the 20-day average of 277,121 (relative volume 2.59x). high

Technical Shares at $2.36 are trading above the 200-day MA of $2.19 after a -2.07% day.

Peers on Argus 1 Down

THAR fell -2.07% while close biotech peers showed mixed moves (e.g., LPCN +15.05%, EDSA +2.7%, BLRX -1.32%), pointing to stock-specific dynamics rather than a coordinated sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 12	CFO appointment	Neutral	-5.5%	New CFO to oversee capital planning and Canton Coin treasury expansion.
Nov 13	FDA feedback TH104	Positive	-6.5%	FDA concurred with TH104 PK modeling plan toward potential 505(b)(2) NDA.
Nov 06	Private placement close	Positive	+4.0%	Closed <b>$545M</b> raise at <b>$3.075</b> to fund Canton Coin strategy.
Nov 03	Private placement announce	Positive	+8.5%	Announced ~<b>$540M</b> private placement to launch Canton Coin treasury.
Aug 20	TH104 PK results	Positive	+206.8%	Positive TH104 simulations with ~<b>30-min</b> onset and ~<b>24-hour</b> protection.

Pattern Detected

THAR has seen strong positive reactions to financing and strategic Canton Coin announcements, but recent biotech and corporate updates have sometimes been met with negative moves, indicating inconsistent reactions to fundamentally positive news.

Recent Company History

Over the last six months, Tharimmune has blended biotech progress with a major digital-asset strategy shift. Positive TH104 pharmacokinetic data on Aug 20, 2025 coincided with a +206.84% move. In early November, a announced and then closed private placement of about $540–545 million to fund its Canton Coin treasury strategy saw shares rise 8.47% and 4.01%. More recently, positive FDA feedback on TH104 on Nov 13 and a CFO appointment tied to the Canton strategy on Dec 12 were followed by -6.52% and -5.53% moves, respectively. Today’s DTCC/Canton commentary builds on this digital-asset focus.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-10-17

Tharimmune has an active Form S-3 resale registration filed on Oct 17, 2025 for 326,750 shares issuable upon warrant exercises. The company is not selling shares under this prospectus and would only receive cash if warrants are exercised for cash. The shelf runs until Oct 17, 2028 and has been used in connection with 424B3 and 424B5 prospectus supplements.

Market Pulse Summary

This announcement highlights Tharimmune’s positioning within the Canton Network as DTCC moves to tokenize U.S. Treasury securities. The company previously raised $545 million in November 2025 to build a Canton Coin-focused treasury and seek roles such as validator and application investor. With Canton reportedly processing $9 trillion in monthly volume and 700,000 daily transactions, the news underscores Tharimmune’s bet on institutional blockchain rails while its clinical-stage biotech programs, including TH104, remain another key area to watch.

Key Terms

tokenize financial

"announcement of its partnership with Digital Asset Holdings to tokenize U.S. Treasury"

To tokenize is to convert ownership or rights in a real-world asset (like a building, a bond, or a piece of art) into digital tokens recorded on a shared electronic ledger, similar to turning a whole object into many collectible trading cards that each represent a slice of the item. For investors this can make large or illiquid assets easier to buy, sell or split into smaller pieces, speed up transfers, and increase transparency, while also introducing new technology and regulatory risks.

U.S. Treasury securities financial

"to tokenize U.S. Treasury securities custodied at DTCC on the Canton Network"

U.S. Treasury securities are loans the U.S. government sells to raise cash, issued as short-term bills and longer-term notes and bonds that pay interest and return your principal at maturity. Investors watch them because they are treated as very low-risk benchmark investments—like a financial “anchor” whose yields set the baseline for borrowing costs, bond prices and stock valuations across markets.

repo transactions financial

"movement of treasury and repo transactions onchain"

Repo transactions are short-term agreements where one party sells securities, like government bonds, to another with the promise to buy them back later at a slightly higher price. They function like a temporary loan secured by the securities, providing quick access to cash. Investors and financial institutions use repos to manage liquidity and funding needs efficiently.

AI-generated analysis. Not financial advice.

Milestone Underscores Accelerating Institutional Adoption of Blockchain Technology and Aligns with Tharimmune's Canton Coin Treasury Strategy

NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today issued commentary following the Depository Trust & Clearing Corporation's ("DTCC") announcement of its partnership with Digital Asset Holdings to tokenize U.S. Treasury securities custodied at DTCC on the Canton Network.

Mark Wendland, CEO of Tharimmune, commented:

"DTCC's announcement represents another meaningful step in the structural shift toward onchain financial rails. With more than $30 trillion in U.S. Treasury assets currently custodied with DTCC, this collaboration is an unmatched opportunity to realize value through the movement of treasury and repo transactions onchain.

Institutional adoption of blockchain technology depends on a critical capability that the Canton Network uniquely delivers: programmable privacy. The configurable privacy on the Canton Network allows market participants to capitalize on instantaneous settlement without disclosing the "who" behind the trade to any party other than authorized counterparties and regulators.

We see the value proposition of the Canton Network becoming increasingly tangible, having recently reached $9 trillion in monthly transaction volume across more than 700,000 daily transactions. DTCC's selection of Canton Network will dramatically accelerate the modernization of market infrastructure, and Tharimmune is well-positioned to support and participate in this growth."

Tharimmune established its digital asset treasury strategy in November 2025 with a $545 million private placement. The strategy is designed to directly support the Canton Network's expansion and long-term ecosystem development. In addition to acquiring Canton Coin, Tharimmune is pursuing roles as a Super Validator and application investor, deepening its integration within the network's infrastructure and transaction economy.

About Tharimmune

Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit www.tharimmune.com.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.

Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com

Investors:
ir@tharimmune.com

Twitter/X: @TharimmuneInc
LinkedIn: https://www.linkedin.com/company/tharimmune-inc
Website: https://tharimmune.com

 

View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-statement-on-dtccs-initiative-to-tokenize-us-treasury-securities-on-the-canton-network-302645591.html

SOURCE Tharimmune, Inc.

FAQ

What did Tharimmune announce about DTCC's tokenization on December 18, 2025?

Tharimmune said DTCC's move to tokenize U.S. Treasuries on Canton Network underscores institutional adoption and supports Tharimmune's Canton Coin strategy.

How large is Tharimmune's digital asset commitment announced in November 2025 (THAR)?

Tharimmune established a digital asset treasury strategy via a $545 million private placement in November 2025.

What transaction volume did Tharimmune cite for the Canton Network?

Tharimmune cited $9 trillion in monthly transaction volume and over 700,000 daily transactions on Canton Network.

How does DTCC's custody footprint relate to the tokenization initiative mentioned by Tharimmune?

Tharimmune noted DTCC currently custodians about $30 trillion in U.S. Treasuries, framing the tokenization as materially large.

What roles is Tharimmune pursuing within the Canton Network (THAR)?

Tharimmune is acquiring Canton Coin and pursuing roles as a Super Validator and as an application investor to deepen integration.

Does Tharimmune's announcement affect its biotech operations?

The statement says Tharimmune continues to operate clinical-stage biotech R&D alongside its Canton Network activities.